Perioperative Management of Lovenox (Enoxaparin)
General Recommendations
- The American College of Chest Physicians recommends administering the last preoperative dose of therapeutic Lovenox 24 hours before surgery to minimize bleeding risk 1, 2, 3
- This timing allows for approximately 4-5 half-lives to elapse before surgery, minimizing residual anticoagulant effect 4
- Resume therapeutic-dose Lovenox 48-72 hours after surgery when hemostasis is adequate for high bleeding risk procedures 3, 1
- For low bleeding risk procedures, resume Lovenox at previous therapeutic dose 24 hours after surgery 4, 1
Rationale for 24-Hour Preoperative Discontinuation
- Studies show that when Lovenox is discontinued only 12 hours before surgery, >90% of patients have detectable anticoagulant effect at the time of surgery 1
- Approximately 34% of patients still have therapeutic anticoagulant levels when Lovenox is stopped only 12 hours preoperatively 1
- The elimination half-life of Lovenox is 3-5 hours, which informs the pre-operative interruption timing 1
Special Considerations
- For patients on warfarin requiring bridging with Lovenox, the same timing principles apply, with warfarin stopped 5 days before surgery and therapeutic Lovenox begun approximately 3 days before surgery 5, 2, 6, 4
- Patients with renal impairment may require longer discontinuation periods due to delayed clearance of Lovenox 7, 4
- Consider individual patient factors, including renal function, when determining exact timing 4
Post-Operative Resumption
- For high bleeding risk procedures, resume therapeutic Lovenox 48-72 hours after surgery 3, 1
- For low bleeding risk procedures, resume therapeutic Lovenox 24 hours after surgery 4, 1
- Consider prophylactic doses initially if bleeding risk remains elevated 5, 4